Vivani Medical Inc. Asset Resilience Ratio
Vivani Medical Inc. asset resilience ratio. Vivani Medical Inc. (VANI) has an Asset Resilience Ratio of 49.91% as of December 2017. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Vivani Medical Inc. to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Vivani Medical Inc. (2012–2017)
Asset resilience ratio of Vivani Medical Inc. from 2012 to 2017. This chart shows how Vivani Medical Inc.'s Asset Resilience Ratio has changed over time. Read Vivani Medical Inc. debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Vivani Medical Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see VANI current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $7.24 Million | 49.91% |
| Total Liquid Assets | $7.24 Million | 49.91% |
Asset Resilience Insights
- Very High Liquidity: Vivani Medical Inc. maintains exceptional liquid asset reserves at 49.91% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Vivani Medical Inc. Industry Peers by Asset Resilience Ratio
Compare Vivani Medical Inc.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Hyloris Developmentsen Sa
BR:HYL |
Biotechnology | 1.36% |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
Biotechnology | 0.00% |
|
Oruka Therapeutics, Inc.
NASDAQ:ORKA |
Biotechnology | 53.11% |
|
Gempharmatech Co. Ltd. A
SHG:688046 |
Biotechnology | 23.95% |
|
Vor Biopharma Inc
NASDAQ:VOR |
Biotechnology | 74.48% |
|
Inventiva S.A
PA:IVA |
Biotechnology | 52.73% |
|
Sunmax Biotechnology Co Ltd
TWO:4728 |
Biotechnology | 10.53% |
|
Guangdong VTR Bio-Tech Co Ltd
SHE:300381 |
Biotechnology | 4.98% |
Vivani Medical Inc. Asset Resilience Ratio by Year (2012–2017)
Vivani Medical Inc. asset resilience ratio by year from 2012 to 2017. The table below shows the annual Asset Resilience Ratio data for Vivani Medical Inc..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 49.91% | $7.24 Million | $14.50 Million | -11.57pp |
| 2016-12-31 | 61.48% | $10.34 Million | $16.81 Million | +5.83pp |
| 2015-12-31 | 55.65% | $15.72 Million | $28.25 Million | -23.29pp |
| 2014-12-31 | 78.94% | $34.00 Million | $43.07 Million | +10.99pp |
| 2013-12-31 | 67.95% | $8.61 Million | $12.67 Million | +14.02pp |
| 2012-12-31 | 53.93% | $4.31 Million | $7.99 Million | -- |
About Vivani Medical Inc.
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the t… Read more